podcast  PDF


Management of term infants at increased risk for early onset bacterial sepsis

Posted: Jan 13 2017

The Canadian Paediatric Society gives permission to print single copies of this document from our website. For permission to reprint or reproduce multiple copies, please see our copyright policy.

Principal author(s)

Ann L Jefferies, Canadian Paediatric Society , Fetus and Newborn Committee


Early-onset neonatal bacterial sepsis (EOS) is sepsis occurring within the first seven days of life. This statement provides updated recommendations for the care of term (≥37 weeks’ gestational age) newborns at risk of EOS, during the first 24 h of life. Maternal group B streptococcal (GBS) colonization in the current pregnancy, GBS bacteruria, a previous infant with invasive GBS disease, prolonged rupture of membranes (≥18 h), and maternal fever (temperature ≥38oC) are the factors most commonly associated with EOS. These risk factors are additive; the presence of more than one factor increases the likelihood of EOS. At present, there is no laboratory test, including white blood cell indices, that has sufficient sensitivity to allow clinicians to safely rule out EOS. All unwell infants with clinical signs suggesting sepsis must be treated empirically with antibiotics, once cultures have been taken. The management of well-appearing, at-risk term infants depends on the number of risk factors (including maternal GBS colonization) and whether maternal intrapartum antibiotic prophylaxis for GBS was used. In some cases, management should be individualized. Careful assessment and observation of these at-risk infants are a fundamental component of appropriate care.

Key Words: Chorioamnionitis; Early-onset sepsis; Group B streptococcus; Newborn


Early-onset neonatal bacterial sepsis (EOS) has been defined as sepsis occurring within the first seven days of life[1]; most infants become symptomatic within 24 h of birth.[2]-[4] EOS usually results from vertical transmission and, consequently, is associated with organisms that colonize the birth canal. Organisms can ascend to the amniotic fluid, colonizing the infant, or the infant may become colonized during passage through the birth canal. Invasive infection may occur if the skin barrier is broached. Aspiration of infected fluid or transplacental passage of organisms may also result in invasive infection. Following implementation of universal maternal screening for group B streptococcus (GBS) and intrapartum antibiotic prophylaxis (IAP), the incidence of early onset GBS (EOGBS) infection has decreased without concomitant decrease in the incidence of other pathogens. The net result has been an overall decrease in the incidence of EOS. In 2013, 0.5% of infants admitted to Canadian neonatal intensive care units had EOS.[5] In the United States, the overall incidence of EOS has been estimated at 0.77 cases per 1000 live births, with a case fatality rate of 10.9%.[6] Incidence and case fatality rates decrease with increasing gestational age (GA).

In 2007, the Canadian Paediatric Society published recommendations for management of infants at increased risk of EOS.[7] Subsequently, guidelines were published by the United States Centers for Disease Control and Prevention (CDC) and the American Academy of Pediatrics (AAP).[1][8]-[10] As the incidence of EOS is declining, new questions are being raised about the utility of predictive tools and the exposure of well-appearing newborns to antibiotics.[11][12] This statement provides updated recommendations for the care of term (≥37 weeks’ GA) newborns with risk factors for EOS, during the first 24 h of life.


A search of MEDLINE and the Cochrane database was undertaken and updated in 2015. Search terms included “early-onset sepsis”, “neonatal sepsis”, “neonatal meningitis”, “chorioamnionitis”, “intrapartum fever” and “prolonged rupture of membranes”. Reference lists of published guidelines and articles were reviewed. Chosen articles focused on term populations; those restricted to late-onset sepsis were excluded. A modification of the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) system was used to describe the recommendations.[13]

Maternal and neonatal risk factors for early onset sepsis

Risk factors

The risk factors associated most frequently with EOS in term infants are summarized in Table 1.[1][14]-[15] The presence of more than one factor increases the likelihood of EOS.[15]-[17] Recent case-control studies have shown “dose-dependent” rather than dichotomous relationships between the degree of maternal fever, duration of ruptured membranes and lower GA with increasing risk of EOS.[17][18] Puopolo and colleagues have developed a calculator which considers maternal GBS status, intrapartum antibiotic exposure, GA, highest maternal temperature and duration of membrane rupture to estimate the probability of EOS for asymptomatic babies.[17][19] Validation of this algorithm is in progress.

GBS colonization and intrapartum antibiotic prophylaxis

In the absence of IAP, approximately 1% to 2% of infants born to mothers colonized with GBS develop EOGBS sepsis. Current guidelines recommend screening pregnant women for GBS colonization at 35 weeks’ to 37 weeks’ GA and providing IAP for those who screen positive as well as for those with GBS bacteruria or a previous GBS-infected infant.[1][14] If GBS status is unknown, IAP should be offered if any other risk factors (Table 1) are present. Adequate IAP consists of at least one dose given at least 4 h before birth of:

  • IV penicillin G (initial dose 5 million units) or ampicillin (initial dose 2 grams)


  • IV cefazolin (initial dose 2 grams) if the mother is allergic to penicillin but at low risk for anaphylaxis

Penicillin-allergic women with a high risk of anaphylaxis should be treated with IV clindamycin when the GBS isolate is sensitive to clindamycin and erythromycin OR with IV vancomycin when the isolate is resistant to clindamycin or susceptibilities are unknown. Because the efficacy of the latter two regimes has not been confirmed in clinical trials, they should be considered inadequate IAP when managing the neonate.[1] IAP is not recommended when a caesarean section is performed before onset of labour when membranes are intact, regardless of GBS status.[1] It should be noted that IAP does not reduce the incidence of late-onset GBS disease.

Table 1 Maternal and neonatal risk factors for early onset bacterial sepsis in term infants
  • Maternal intrapartum GBS colonization during the current pregnancy
  • GBS bacteruria at any time during the current pregnancy
  • A previous infant with invasive GBS disease
  • Prolonged rupture of membranes ≥18 h
  • Maternal fever (temperature ≥ 38oC)
GBS Group B streptococcus; GA gestational age

Investigations for early onset sepsis

Bacterial cultures

A positive neonatal blood culture remains the gold standard for diagnosing neonatal sepsis, recognizing that maternal antimicrobial therapy may inhibit bacterial growth. Blood may be drawn by peripheral venous or arterial puncture or from a newly inserted catheter, using aseptic technique. An in vitro study showed that at least 1 mL of blood is required for optimal recovery of micro-organisms in low-colony-count sepsis.[20] Drawing blood cultures from multiple sites does not appear to improve the yield of pathogens.[21]

Meningitis is uncommon in newly born infants (incidence 0.25 – 1 / 1000 live births)[22] and it remains controversial whether a lumbar puncture (LP) should be performed routinely as part of the initial investigation for EOS, particularly for term infants. In asymptomatic term infants investigated for EOS, no cases of meningitis were reported in three large observational studies.[2][21][22] Meningitis was similarly very uncommon (0% to 0.3%) in preterm infants investigated for EOS because of respiratory distress.[25][26] However, newborns with positive blood cultures are more likely to have meningitis.[27]-[29] Furthermore, 8% to 40% of infants with early onset meningitis are reported to have negative blood cultures.[27]-[30] These data suggest that an LP should be performed at the outset when there is a strong clinical suspicion of EOS or when signs of meningitis (seizures, bulging fontanelle, irritability, altered neurological status) are present. The LP can be deferred in unstable infants until their condition improves. For term newborns with respiratory distress only, the LP could also be deferred if the infant is monitored closely. An LP must be done whenever the blood culture is positive. The CSF culture may be negative when the LP is performed after antibiotics have been started but pleocytosis, low glucose and/or elevated protein concentration may be observed with meningitis. In term infants, a cerebrospinal fluid (CSF) white blood cell (WBC) count of >20-25 cells/mm3 is considered abnormal; this value has a sensitivity of 79% and specificity of 81% for diagnosing bacterial meningitis.[29] Culture-positive bacterial meningitis may be present with a normal CSF WBC count.[29][30]

Cultures of urine, gastric aspirates and body surface have limited value in the evaluation for EOS and are not recommended for newly born infants.[16]


A complete blood count (CBC) is the most readily available, rapid and economical investigative test for sepsis. Studies have examined individual WBC indices, including total WBC count, absolute neutrophil count (ANC), and ratio of immature to total neutrophils (I:T ratio), as well as combinations. Following birth, the neutrophil count of healthy term neonates rises, peaking between 6 h to 8 h of age; higher counts are associated with labour and duration of labour, likely because increasing catecholamine levels stimulate demargination of neutrophils.[31]-[33] Four recent studies examined large cohorts of term and late preterm infants, many of whom were asymptomatic but investigated because of septic risk factors.[4][33]-[35] A low total WBC count (<5 x 109/L) or low ANC (<1.5 x 109/L) was more likely to be associated with EOS than an increased I:T ratio (>0.2) or high total WBC (>30 x 109/L). The positive predictive accuracies of all WBC indices were low, as were the sensitivities, the latter drawing into question the tests’ role in allowing clinicians to confidently rule out sepsis.[35]

The predictive abilities of WBC indices improve with time after birth. After 4 h, the likelihood ratio in detecting sepsis for a WBC count <5 x 109/L was 80.5, for ANC <1 x 109/L was 115, and for an I:T ratio >0.6 was 10.7.[33] This means that in newborns with an abnormal test, the post-test probability of sepsis increased significantly. However, for most asymptomatic infants, who have a low pre-test probability for sepsis, WBC indices demonstrate only modest likelihood ratios which are not helpful for confidently ruling in or ruling out sepsis.[33][36] When there is clinical uncertainty in well infants (eg, multiple risk factors, chorioamnionitis), WBC indices, particularly in combination, may be of some help if obtained after 4 h of age.[18][33][36] Waiting to obtain a CBC should never delay investigation and starting antibiotics when clinical signs of sepsis are present.

Reported sensitivities for EOS of C-reactive protein (CRP), an acute-phase protein synthesized in response to tissue injury, vary widely; sensitivity is lowest early in the infectious process.[37] The diagnostic accuracy of a single CRP at the time of initial investigation is poor, and a normal result should not delay initiation of antibiotics for a symptomatic infant. CRP measured serially may be helpful in determining duration of empiric antibiotic therapy. However, multiple conditions can be associated with the inflammatory response and a single elevated CRP should not be used to prolong antibiotic therapy.[38] Although procalcitonin, a peptide precursor of calcitonin, has shown moderate to good accuracy in the diagnosis of EOS,[39]-[40] it is not readily and rapidly available. The utility of other biomarkers, including interleukin-6, interleukin-8, tumour necrosis factor and neutrophil CD64, on their own or combined with WBC indices, requires confirmation.


Unwell infants

Initial signs of sepsis may be subtle and include respiratory distress, temperature instability, tachycardia, seizures, hypotonia, lethargy, poor peripheral perfusion, hypotension and acidosis. In an analysis of 2785 symptomatic and asymptomatic infants with birth weights ≥2000 g, the sensitivity and negative predictive value of clinical signs were 92% and 99% respectively, in contrast to sensitivities of <50% for low ANC and increased I:T ratio.[2] Because invasive disease can progress rapidly, all infants with clinical signs of sepsis must be treated immediately with intravenous antibiotics following prompt investigation that includes a CBC, blood culture and LP as well as chest x-ray if respiratory distress is present. No screening tests have sufficiently high sensitivity to prevent therapy. Although the CBC is not a useful screening test, septic infants frequently have abnormal values and a CBC should be done at the time of initial blood culture.

Negative maternal GBS cultures or use of intrapartum antibiotics, including GBS IAP, should not change management of symptomatic infants. GBS disease occurs in the presence of negative maternal GBS cultures[9] and, occasionally, following adequate IAP. IAP does not affect the frequency of sepsis caused by other organisms.[41]

Respiratory distress is a common initial presentation of many term newborns, especially after caesarean section, and often resolves within several hours. Infants who appear stable and lack perinatal risk factors for sepsis can be observed closely for up to 6 h to determine whether respiratory distress resolves before investigating for sepsis and starting antibiotics.[18]

Empirical antibiotic therapy should be directed toward the most common bacteria associated with EOS. In term infants born in Canada and the United States, the most common pathogen is GBS followed by Escherichia coli, Streptococcus viridans, Streptococcus pneumoniae, Enterococcus, Enterobacter, Staphylococcus aureus and Haemophilus influenzae.[42] EOS as a result of Listeria monocytogenes is now very uncommon, but incidence may increase during outbreaks related to food contamination. Ampicillin and an aminoglycoside provide coverage for GBS, E coli and most other common pathogens. Knowledge of maternal symptoms and culture results, as well as local sensitivity patterns, should be taken into account. When meningitis is suspected, infants should receive antibiotics that penetrate into CSF, in appropriate doses. When cultures are positive and sensitivities determined, therapy can be modified to the most appropriate antimicrobial agents.

Well-appearing term infants with risk factors

The incidence of EOS in asymptomatic term infants with risk factors (Table 1), including maternal GBS colonization, is very low (~1%),[2][4] but is still higher than for the general birth population. Clinicians must balance not treating the small number of infected infants with minimizing invasive investigation and antibiotic exposure for many at-risk but well infants without infection.

GBS-positive mothers with adequate IAP, no additional risk factors: If a GBS-positive woman receives adequate IAP and her infant appears healthy, no investigation or treatment is necessary. Antibiotic use during labour does not appear to delay the onset of clinical signs of infection, with 95% of septic newborns presenting in the first 24 h of life regardless of antibiotic exposure.[3] Berger has estimated that prolonging hospitalization for these infants from 24 h to 48 h has minimal effects on health outcomes but substantially increases cost.[43] If other discharge criteria are met, these infants can be discharged home after 24 h, providing they remain well, there is ready access to health care, and parents understand the signs of sepsis and when to seek medical care.

GBS-positive mothers with inadequate IAP, no additional risk factors: The risk of invasive EOGBS disease in infants born to GBS-positive mothers who received inadequate or no IAP is 1% to 2%.[1] In three studies comprising 3101 infants born to mothers with inadequate or no IAP, only two infants (0.06%) had EOGBS sepsis; both were symptomatic within the first 24 h.[44]-[46] The CBC was of limited value. These infants should have a careful physical assessment after birth, close in-hospital observation (including vital signs every 3 h to 4 h) for at least 24 h, and reassessment to confirm well-being if discharge is planned between 24 h and 48 h. A CBC is not indicated because the sensitivity of clinical signs is higher than that of WBC indices.

Infants who are well when reassessed after 24 h and have met other discharge criteria can be discharged home, providing parents have been counselled about signs of sepsis and have ready access to health care. Parental understanding of when to seek medical care should be confirmed. If these conditions cannot be met, infants should be observed in hospital until 48 h of age.

GBS-positive mothers with additional risk factors, with and without IAP: Maternal fever and prolonged rupture of membranes increase the likelihood of EOS in infants born to women colonized with GBS.[47] Although IAP decreases the risk of EOGBS infection in these infants, their risk is still higher compared with infants born to GBS-positive mothers without additional risk factors.[2][15][17][48] Currently, there is insufficient information to specifically guide practice when multiple risk factors are present. Clinicians should consider the severity of each factor as well as intrapartum antibiotic exposure and the clinical status of each infant to determine an individualized management plan. At a minimum, these infants should be closely observed in hospital for 24 h to 48 h, with reassessment before discharge. Investigation and treatment for sepsis may be warranted for some infants. A CBC performed after 4 h of age may be of some help in decision-making. In future, a sepsis calculator will likely be helpful.[17]-[19]

Mothers who are GBS-negative or GBS-unknown status, with other risk factors: Risk factors (Table 1) increase the likelihood of EOS for babies born to mothers with negative or unknown GBS status and are indications for IAP when GBS status is unknown.[9] In asymptomatic newborns, the likelihood of EOS remains low.[4][49] In the era of universal GBS screening, most EOGBS sepsis in term infants occurs in newborns born to mothers who screened GBS-negative.[17][27] Antibiotics given during labour decrease the incidence of both EOGBS and non-GBS EOS, but to a lesser extent with non-GBS infection, with a reported efficacy of 85% for GBS disease and 68% for non-GBS disease, adjusted for maternal fever.[50]

When maternal GBS status is unknown or negative and a single risk factor present, asymptomatic infants can be managed in the same manner as infants born to GBS-positive mothers, depending on whether IAP was adequate, inadequate or not given. If multiple risk factors are present, management should be individualized.

Chorioamnionitis: Chorioamnionitis (acute inflammation of the fetal membranes) is usually diagnosed on the basis of maternal temperature >38oC plus two other signs (uterine tenderness, maternal or fetal tachycardia, foul/purulent amniotic fluid, maternal leukocytosis).[51] Chorioamnionitis remains difficult to diagnose clinically because the prevalence of maternal fever during labour is high, especially after epidural analgesia[52] or prolonged labour.

The incidence of EOS in term infants born to mothers with chorioamnionitis is low. Three studies comprising 1892 neonates ≥35 weeks’ GA exposed to maternal chorioamnionitis identified 15 infants (0.8%) with positive blood cultures,[34][53][54] and a further study reported no EOS in asymptomatic term infants born after histologic chorioamnionitis.[55] Broad-spectrum intrapartum antibiotics reduce the risk of EOS in general by 82% and EOGBS sepsis by 86%.[15] Escobar reported that chorioamnionitis was not associated with EOS if mothers received antibiotics during labour.[2]

Although both the CDC and the AAP currently recommend that all term infants born to women with suspected chorioamnionitis have cultures and antibiotic therapy,[1][8]-[10] a recent commentary suggested that alternative approaches be considered.[11][56] More individualized strategies may allow the number of infants treated with antibiotics to be decreased safely, as shown in a recent retrospective review of 698 infants born to mothers with chorioamnionitis.[57] If term infants are examined after birth and are well, close observation in hospital for at least 24 h is a reasonable approach. When a mother has multiple risk factors, including chorioamnionitis, has not received intrapartum antibiotics and/or is herself unwell, clinicians may consider investigation and antibiotic therapy for the infant. The LP can be deferred for asymptomatic infants.

Late preterm infants

Preterm birth <37 weeks’ GA is considered a risk factor for infection, and women should receive IAP if GBS colonization is unknown.[1][14] Although specific evidence to guide practice is lacking, infants 35 to 36 weeks’ gestation who are stable enough to be admitted to a mother and baby unit (normal newborn nursery) rather than a special care nursery or neonatal intensive care unit, can be managed in a similar manner to infants ≥37 weeks’ GA.[10] These late preterm infants should be observed for at least 48 h before being discharged home.[58]


(See Figure 1)

Recommendations are graded using the GRADE system.[13] It should be noted that this is an area in which few prospective and high quality comparative studies have been done; hence the low quality evidence.

Newly born unwell term infants (≥37 weeks’ GA)

  1. Infants with clinical signs of sepsis (respiratory distress, temperature instability, tachycardia, seizures, hypotonia, lethargy, poor peripheral perfusion, hypotension, acidosis) require prompt investigation, including CBC, blood culture and lumbar puncture, and initiation of empirical intravenous antibiotic therapy. Ampicillin and an aminoglycoside provide coverage for the most common pathogens associated with early onset sepsis (EOS). Infants who have respiratory signs should also have a chest x-ray. (Strong recommendation, moderate quality evidence.)
  2. Infants with early respiratory signs only and without risk factors for sepsis may be observed for up to 6 h before initiating investigations for sepsis and antibiotic therapy. (Strong recommendation, low quality evidence.)

Newly born well-appearing infants (≥37 weeks’ GA)

  1. White blood cell (WBC) indices (total WBC count, absolute neutrophil count [ANC], ratio of immature to total neutrophils) or a single C-reactive protein should not be used routinely as screening or diagnostic tests for EOS, nor to routinely exclude EOS. (Strong recommendation, moderate quality evidence.)
  2. For GBS-positive mothers with adequate intrapartum antibiotic prophylaxis (IAP), no additional risk factors OR mothers who are GBS-negative or GBS-unknown status, with one other risk factor and adequate IAP: Infants do not require investigation or treatment for sepsis. They may be discharged home after 24 h if they remain well, meet other discharge criteria and if parents understand signs of sepsis and when to seek medical care. (Strong recommendation, high quality evidence for GBS-positive mother, adequate IAP; low quality evidence for GBS-negative or –unknown mothers.)
  3. For GBS-positive mothers with inadequate IAP and no additional risk factors OR mothers who are GBS-negative or GBS-unknown status, with one other risk factor and inadequate IAP: Infants should be examined at birth, observed closely in hospital with vital signs every 3 h to 4 h, and reassessed before discharge home. They may be discharged home after 24 h if they remain well and meet other discharge criteria, providing there is ready access to health care and the parents understand and are able to seek medical care if the infant develops signs of sepsis. Routine investigation or treatment is not required. (Strong recommendation, low quality evidence.)
  4. Multiple risk factors for sepsis and/or chorioamnionitis: Infants should be investigated and treated using an individualized approach that includes consideration of the severity of risk factors and maternal antibiotic therapy. At minimum, infants should have close observation in hospital for at least 24 h with vital signs every 3 h to 4 h and reassessment before discharge. A CBC done after 4 h of age may be helpful; WBC <5 x 109/L and ANC <1.5 x 109/L have the highest positive predictive value. Some infants may warrant investigation and antibiotic therapy. (Weak recommendation, low quality evidence.)

Well late preterm infants 35 to 36 weeks’ GA

  1. If infants are stable enough to remain with their mother in a mother and baby unit, they can be managed similar to infants ≥37 weeks’ GA, but should be observed in hospital for at least 48 h. (Weak recommendation, low quality evidence.)


This position statement has been reviewed by the Community Paediatrics and Infectious Disease and Immunization Committees of the Canadian Paediatric Society. It was also reviewed by representatives from the College of Family Physicians of Canada and the Society of Obstetrics and Gynaecologists of Canada.


Members: Ann L Jefferies MD (past Chair), Thierry Lacaze-Masmonteil MD (Chair), Leigh Anne Newhook MD (Board Representative), Leonora Hendson MD, Brigitte Lemyre MD, Michael R Narvey MD, Vibhuti Shah MD, ST Sorokan MD (past member)

Liaisons: Linda Boisvert RN, Canadian Association of Neonatal Nurses; Andrée Gagnon MD, College of Family Physicians of Canada; Robert Gagnon MD, Society of Obstetricians and Gynaecologists of Canada; Juan Andrés León MD, Public Health Agency of Canada; Patricia A O’Flaherty MN MEd, Canadian Perinatal Programs Coalition; Eugene H Ng MD, CPS Neonatal-Perinatal Medicine Section; Kristi Watterberg MD, Committee on Fetus and Newborn, American Academy of Pediatrics

Principal author: Ann L Jefferies MD


  1. Verani JR, McGee L, Schrag SJ, Centers for Disease Control and Prevention. Prevention of perinatal Group B streptococcal disease: Revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59(RR-10):1-36.
  2. Escobar GJ, Li D, Armstrong MA, et al. Neonatal sepsis workups in infants /=2000 grams at birth: A population-based study. Pediatrics 2000;106(2 Pt 1):256-63.
  3. Bromberger P, Lawrence JM, Braun D, Saunders B, Contreras RC, Petitti DB. The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants. Pediatrics 2000;106(2 Pt 1):244-50.
  4. Ottolini MC, Lundgren K, Mirkinson LJ, Cason S, Ottolini MG. Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn. Pediatr Infect Dis J 2003;22(5):430-4.
  5. Canadian Neonatal Network Annual Report, 2013: http://www.canadianneonatalnetwork.org/Portal/LinkClick.aspx?fileticket=lreR0871sjA%3d&tabid=39 (Accessed August 8, 2016).
  6. Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J 2011;30(11):937-41.
  7. Barrington KJ, Canadian Paediatric Society Fetus and Newborn Committee. Management of the infant at increased risk for sepsis. Paediatr Child Health 2007;12(10):893-905.
  8. Baker CJ, Byington CL, Polin RA, Committee on Infectious Diseases; Committee on Fetus and Newborn, American Academy of Pediatrics. Policy statement – Recommendations for the prevention of perinatal group B streptococcal (GBS) disease. Pediatr 2011;128(3):611-6.
  9. Polin RA; Committee on Fetus and Newborn, American Academy of Pediatrics. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 2012;129(5):1006-15.
  10. Brady MT, Polin RA. Prevention and management of infants with suspected or proven neonatal sepsis. Pediatrics 2013;132(1):166-8.
  11. Benitz WE, Wynn JL, Polin RA. Reappraisal of guidelines for management of neonates with suspected early-onset sepsis. J Pediatr 2015;166(4):1070-4.
  12. Cotton CM. Antiobiotic stewardship: Reassessment of guidelines for management of neonatal sepsis. Clin Perinatol 2015;42(1):195-206.
  13. Guyatt G, Gutterman D, Baumann MH, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an American College of Chest Physicians task force. Chest 2006;129(1): 174-81.
  14. Money D, Allen VM; Infectious Diseases Committee, Society of Obstetricians and Gynecologists of Canada. The prevention of early-onset neonatal Group B streptococcal disease. J Obstet Gynaecol Can 2013;35(10):939-51.
  15. Benitz WE, Gould JB, Druzin ML. Risk factors for early-onset group b streptococcal sepsis: Estimation of odds ratios by critical literature review. Pediatrics 1999;103(6):e77.
  16. Gerdes JS. Diagnosis and management of bacterial infections in the neonate. Pediatr Clin N Am 2004;51(4):939-59.
  17. Puopolo KM, Draper D, Wi S, et al. Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors. Pediatr 2011;128(5):e1155-63.
  18. Escobar GJ, Puopolo KM, Wi S, et al. Stratification of risk of early-onset sepsis in newborns ? 34 weeks’ gestation. Pediatrics 2014;133(1):30-6.
  19. Mukhopadhyay S, Dukhovny D, Mao W, Eichenwald EC, Puopolo K. 2010 perinatal GBS prevention guideline and resource utilization. Pediatrics 2014;133(2):196-203.
  20. Schelonka RL, Chai MK, Yoder BA, Hensley D, Brockett RM, Ascher DP. Volume of blood required to detect common neonatal pathogens. J Pediatr 1996;129(2):275-8.
  21. Sarkar S, Bhagat I, DeCristofaro JD, Wiswell TE, Spitzer AR. A study of the role of multiple site blood cultures in the evaluation of neonatal sepsis. J Perinatol 2006;26(1):18-22.
  22. Wiswell TE, Baumgart S, Gannon CM, Spitzer AR. No lumbar puncture in the evaluation for early neonatal sepsis: Will meningitis be missed? Pediatrics 1995;95(6):803-6.
  23. Fielkow S, Reuter S, Gotoff SP. Cerebrospinal fluid examination in symptom-free infants with risk factors for infection. J Pediatr 1991;119(6):971-3.
  24. Johnson CE, Whitwell JK, Pethe K, Saxena K, Super DM. Term newborns who are at risk for sepsis: Are lumbar punctures necessary? Pediatrics 1997;99(4):E10.
  25. Eldadah E, Frenkel LD, Hiatt IM, Hegyi T. Evaluation of routine lumbar punctures in newborn infants with respiratory distress syndrome. Pediatr Infect Dis J 1987;6(3):243-6.
  26. Weiss MG, Ionides SP, Anderson CL. Meningitis in premature infants with respiratory distress: Role of admission lumbar puncture. J Pediatr 1991;119(6):973-5.
  27. Stoll BJ, Hansen NI, Sánchez PJ, et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Early onset neonatal sepsis: The burden of group B Streptococcal and E. coli disease continues. Pediatrics 2011;127(5):817-26.
  28. May M, Daley AJ, Donath S, Isaacs D; Australasian Study Group for Neonatal Infections. Early onset neonatal meningitis in Australia and New Zealand, 1992-2002. Arch Dis Child Fetal Neonatal Ed 2005;90(4):F324-7.
  29. Garges HP, Moody MA, Cotton CM, et al. Neonatal meningitis: What is the correlation among the cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters? Pediatrics 2006;117(4):1094-100.
  30. Ansong AK, Smith PB, Benjamin DK, et al. Group B streptococcal meningitis: Cerebrospinal fluid parameters in the era of intrapartum antibiotic prophylaxis. Early Hum Dev 2009;85(10 Suppl):S5-7.
  31. Manroe BL, Weinberg AG, Rosenfield CR, Browne R. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr 1979;95(1):89-98.
  32. Schmutz N, Henry E, Joping J, Christensen RD. Expected ranges for blood neutrophil concentrations of neonates: The Manroe and Mouzinho charts revisited. J Perinatol 2008;28(4):275-81.
  33. Newman TB, Puopolo KM, Wi S, Draper D, Escobar GJ. Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics 2010;126(5):903-9.
  34. Jackson GL, Engle WD, Sendelbach DM, et al. Are complete blood counts useful in the evaluation of asymptomatic neonates exposed to suspected chorioamnionitis? Pediatrics 2004;113(5):1173-80.
  35. Hornik CP, Benjamin DK, Becker KC, et al. Use of the complete blood cellcount in early-onset neonatal sepsis. Pediatr Inf Dis J 2012;31(8):799-802.
  36. Newman TB, Draper D, Puopolo KM, Wi S, Escobar GJ. Combining immature and total neutrophil counts to predict early onset sepsis in term and late preterm newborns: Use of the I/T2. Pediatr Infect Dis J 2014;33(8):798-802.
  37. Hofer N, Zacharias E, Müller W, Resch B. An update on the use of C-reactive protein in early-onset neonatal sepsis: Current insights and new tasks. Neonatology 2012;102(1):25-36.
  38. Lacaze-Masmonteil T, Rosychuk RJ, Robinsom JL. Value of a single C-reactive protein measurement at 18 h of age. Arch Dis Child Fetal Neonatal Ed 2014;99(1):F76-9.
  39. Yu Z, Liu J, Sun Q, Qiu Y, Han S, Guo X. The accuracy of the procalcitonin test for the diagnosis of neonatal sepsis: A meta-analysis. Scand J Infect Dis 2010;42(10):723-33.
  40. Vouloumanou EK, Plessa E, Karageorgopoulos DE, Mantadakis E, Falagas ME. Serum procalcitonin as a diagnostic marker for neonatal sepsis: A systematic review and meta-analysis. Intensive Care Med 2011;37(5):747-62.
  41. Sutkin G, Krohn MA, Heine RP, Sweet RL. Antibiotic prophylaxis and non-group B streptococcal neonatal sepsis. Obstet Gynecol 2005;105(3):581-6.
  42. Sgro M, Shah PS, Campbell D, et al; Canadian Neonatal Network. Early-onset neonatal sepsis: Rate and organism pattern between 2003 and 2008. J Perinatol 2011;31(12):794-8.
  43. Berger MB, Xu X, Williams JA, Van de Ven CJ, Mozurlewich EL. Early hospital discharge of infants born to group B streptococci-positive mothers: A decision analysis. BJOG 2012;119(4):439-48.
  44. Buckler B, Bell J, Sams R, et al. Unnecessary workup of asymptomatic neonates in the era of group B streptococcus prophylaxis. Inf Dis Obstet Gynecol 2010:2010:pii:369654.
  45. Cantoni L, Ronfani L, Da Riol R, Demarini S, Perinatal Study Group of the Region Friuli-Venezia Giulia. Physical examination instead of laboratory tests for most infants born to mothers colonized with group B Streptococcus: Support for Centers for Disease Control and Prevention’s 2010 recommendations. J Pediatr 2103;163(2):568-73.
  46. Hashavya S, Beneson S, Ergaz-Shaltiel Z, Bar-Oz B, Averbuch D, Eventov-Friedman S. The use of blood counts and blood cultures to screen neonates born to partially treated group B Streptococcus-carrier mothers for early-onset sepsis: Is it justified? Pediatr Inf Dis J 2011;30(10):840-3.
  47. Boyer KM, Gadzala CA, Kelly PD, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission. J Infect Dis 1983;148(5):810- 6.
  48. Pylipow M, Gaddis M, Kinney JS. Selective intrapartum prophylaxis for group B streptococcus colonization: Management and outcome of newborns. Pediatrics 1994;93(4):631-5.
  49. Shalak LF, Perlman JM, Jackson GL, Laptook AR. Depression at birth in term infants exposed to maternal chorioamnionitis: Does neonatal fever play a role? J Perinatol 2005;25(7):447-52.
  50. Schuchat A, Zywicki SS, Dinsmoor MJ, et al; Prevention of Early-Onset Neonatal Sepsis (PENS) Study Group. Risk factors and opportunities for prevention of early-onset neonatal sepsis: A multicenter case-control study. Pediatrics 2000;105(1 Pt 1):21-6.
  51. Tita ATN, Andrews WW. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol 2010;37(2):33954.
  52. Lieberman E, Lang JM, Frigoletto F, Richardson DK, Ringer SA, Cohen A. Epidural analgesia, intrapartum fever, and neonatal sepsis evaluation. Pediatrics 1997;99(3):415-9.
  53. Jackson GL, Rawiki P, Sendelbach D, Manning MD, Engle WD. Hospital course and short-term outcomes of term and late preterm neonates following exposure to prolonged rupture of membranes and/or chorioamnionitis. Pediatr Infect Dis J 2012;31(1):89-90.
  54. Kiser C, Nawab U, McKenna K, Aghai ZH. Role of guidelines on length of therapy in chorioamnionitis and neonatal sepsis. Pediatrics 2014;133(6):992-8.
  55. Cuna A, Hakima L, Tseng YA, et al. Clinical dilemma of positive histologic chorioamnionitis in term newborn. Front Pediatr 2014;2:27.
  56. Higgins RD, Saade G, Polin RA, et al; Chorioamnionitis Workshop Participants. Evaluation and management of women and newborns with a maternal diagnosis of chorioamnionitis: Summary of a workshop. Obstet Gynecol 2016;127(3):426-36.
  57. Shakib J, Buchi K, Smith E, Young PC. Management of newborns born to mothers with chorioamnionitis: Is it time for a kinder, gentler approach? Acad Pediatr2015;15(3):340-4.
  58. Whyte RK, Fetus and Newborn Committee, Canadian Paediatric Society. Safe discharge of the late preterm infant. Paediatr Child Health 2010;15(10):655-66.

Disclaimer: The recommendations in this position statement do not indicate an exclusive course of treatment or procedure to be followed. Variations, taking into account individual circumstances, may be appropriate. Internet addresses are current at time of publication.